Chronic Graft Versus Host Disease clinical trials

Explore recruiting chronic graft versus host disease clinical trials.

Recruiting chronic graft versus host disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Graft Versus Host Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Assessment of Tolerance and Effectiveness of Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, multicenter, Phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD)

Belgium, Sweden, Netherlands, Germany, Denmark, Spain +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy

Czechia, Finland, Austria, France, Netherlands, Ireland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab (INCA034176) and Corticosteroids as Initial Treatment for Chronic Graft-Versus Host Disease (AXemplify 357)

Italy, Denmark, Spain, Ireland, France, Germany +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Randomized, Open-Label Study Of Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Spain, Belgium, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Study of Q702 in Subjects with Relapsed or Refractory Chronic Graft-versus-Host Disease (cGVHD)

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Chronic Graft Versus Host Disease trials by city

Chronic Graft Versus Host Disease in Toronto Chronic Graft Versus Host Disease in Vancouver Chronic Graft Versus Host Disease in Montreal Chronic Graft Versus Host Disease in Calgary Chronic Graft Versus Host Disease in Edmonton Chronic Graft Versus Host Disease in Ottawa Chronic Graft Versus Host Disease in Winnipeg Chronic Graft Versus Host Disease in Quebec City Chronic Graft Versus Host Disease in Hamilton Chronic Graft Versus Host Disease in Kitchener Chronic Graft Versus Host Disease in London Chronic Graft Versus Host Disease in Halifax Chronic Graft Versus Host Disease in New York Chronic Graft Versus Host Disease in Los Angeles Chronic Graft Versus Host Disease in Chicago Chronic Graft Versus Host Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease